Replies to post #151731 on Biotech Values

[jbog]

I thought it was obvious. Of course I understand that Merck can make money by selling drugs in china and be part of your GTW group.

But at the same time I also know that merck can't support its current market valuation selling at those prices. How has your GTW portfolio done against the S&P this year?

I don't see one international doing good besides apple. It shows that a good company comes done to innovation and pricing power.